May 15 |
PAVmed Inc (PAVM) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ...
|
May 15 |
Q1 2024 PAVmed Inc Earnings Call
|
May 14 |
PAVmed Inc. (PAVM) Q1 2024 Earnings Call Transcript
|
May 14 |
PAVmed Non-GAAP EPS of -$0.99 beats by $0.56, revenue of $1.01M misses by $0.03M
|
May 14 |
PAVmed Provides Business Update and First Quarter 2024 Financial Results
|
May 13 |
PAVmed Q1 2024 Earnings Preview
|
May 13 |
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
|
May 9 |
Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall
|
May 7 |
Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors
|
May 3 |
PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024
|